XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Intangible Assets
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

NOTE 5 INTANGIBLE ASSETS

 

Finite-lived Intangible Assets

 

The components of intangible assets were as follows:

 

   

As of September 30, 2023

    As of December 31, 2022  
   

Gross Carrying Costs

   

Accumulated Amortization

   

Net Carrying Amount

   

Gross Carrying Costs

   

Accumulated Amortization

   

Impairment

   

Net Carrying Amount

 

Patents & Trademarks

  $ 535,096     $ (275,776 )   $ 259,320     $ 509,141     $ (255,276

)

  $ -     $ 253,865  

Developed Technology

    -       -       -       3,500,000       (386,459

)

    (3,113,541

)

    -  

Customer Relationships

    -       -       -       200,000       (22,083

)

    (177,917

)

    -  

Tradename

    -       -       -       80,000       (22,083

)

    (57,917

)

    -  

Total

  $ 535,096     $ (275,776 )   $ 259,320     $ 4,289,141     $ (685,901

)

  $ (3,349,375

)

  $ 253,865  

 

Amortization expense, recorded within general and administrative expenses, was $6,863 and $103,805 during the three months ended September 30, 2023 and 2022, respectively, and $20,563 and $310,695 during the nine months ended September 30, 2023 and 2022, respectively.

 

The following table outlines the estimated future amortization expense related to intangible assets held as of September 30, 2023:

 

Year ending December 31,

 

Expense

 

Remainder of 2023

  $ 6,863  

2024

    27,451  

2025

    27,451  

2026

    27,451  

2027

    27,451  

Thereafter

    142,653  

Total

  $ 259,320  

 

The Company recognized no impairment of its finite-lived intangible assets during the three and nine months ended September 30, 2023 and 2022.

 

Goodwill

 

As of September 30, 2022, the Company concluded that the goodwill acquired in connection with the acquisition of zPREDICTA Inc., the Company’s former wholly owned subsidiary, was fully impaired and recognized an impairment loss on goodwill of $7,231,093 during the nine months then ended. As of September 30, 2023, the cumulative impairment of goodwill recorded was $7,231,093.

 

The goodwill acquired by the Company in connection with the acquisition of Helomics was zero as of both September 30, 2023 and December 31, 2022. The cumulative impairment of goodwill recorded was $23,790,290.